e-learning
resources
Munich 2006
Tuesday 05.09.2006
Bronchiolitis in infancy, treatment and outcome
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Montelukast is not preventing reactive airway disease in post respiratory syncytial virus bronchiolitis
K. Sauer, E. Govaere, M. Raes, G. Debildering, K. De Boeck (Leuven, Hasselt, Mont-goddine, Belgium)
Source:
Annual Congress 2006 - Bronchiolitis in infancy, treatment and outcome
Session:
Bronchiolitis in infancy, treatment and outcome
Session type:
Oral Presentation
Number:
4363
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Sauer, E. Govaere, M. Raes, G. Debildering, K. De Boeck (Leuven, Hasselt, Mont-goddine, Belgium). Montelukast is not preventing reactive airway disease in post respiratory syncytial virus bronchiolitis. Eur Respir J 2006; 28: Suppl. 50, 4363
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Cromoglycate in the treatment of respiratory syncytial virus (RSV) bronchiolitis
Source: Eur Respir J 2001; 18: Suppl. 33, 169s
Year: 2001
Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases
Source: Eur Respir J 2001; 18: 1044-1058
Year: 2001
Interleukin-9 in severe respiratory syncytial virus (RSV) bronchiolitis
Source: Eur Respir J 2002; 20: Suppl. 38, 17s
Year: 2002
Reduced interferon-gamma concentration in infants with severe respiratory syncytial virus bronchiolitis
Source: Eur Respir J 2005; 26: Suppl. 49, 27s
Year: 2005
DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis
Source: Eur Respir J 2001; 18: 734-737
Year: 2001
Decreased lung function precedes severe respiratory syncytial virus infection and post-respiratory syncytial virus wheeze in term infants
Source: Eur Respir J 2014; 44: 666-674
Year: 2014
Increasing severity of bronchiolitis in children with respiratory syncytial virus A ON1
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019
Influence of acute bronchiolitis on development of wheezing and asthma: is respiratory syncytial virus ready for the challenge?
Source: Annual Congress 2010 - Bronchiolitis an old disease with still many open questions
Year: 2010
The role of viruses in chronic bronchitis and exacerbations of COPD
Source: Eur Respir Monogr 2013; 60: 68-75
Year: 2013
Are infants with respiratory syncytial virus (RSV) bronchiolitis different from infants with non RSV bronchiolitis for the development of wheezing in the first year of life?
Source: Eur Respir J 2005; 26: Suppl. 49, 27s
Year: 2005
Prevalence of respiratory syncytial virus infection among Philippino children with bronchiolitis
Source: Eur Respir J 2002; 20: Suppl. 38, 17s
Year: 2002
Interleukin 9 concentration in infants with respiratory syncytial virus bronchiolitis
Source: Eur Respir J 2005; 26: Suppl. 49, 28s
Year: 2005
Risk factors for bronchial asthma in infants after respiratory syncytial virus infection
Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood
Year: 2009
Enhanced IL-4 responses in children with a history of respiratory syncytial virus bronchiolitis in infancy
Source: Eur Respir J 2002; 20: 376-382
Year: 2002
Interferon induced gene expression in cells from nasal aspirates of infants with bronchiolitis
Source: Annual Congress 2007 - Bronchiolitis - genetics and immunity
Year: 2007
Human neutrophil elastase (HNE) in acute bronchiolitis
Source: Annual Congress 2006 - Bronchiolitis in infancy, treatment and outcome
Year: 2006
Viral infections of the nose and lung
Source: ISSN=1025-448x, ISBN=1-904097-19-16, page=79
Year: 2001
Neutrophil survival is prolonged in the airways of healthy infants and infants with RSV bronchiolitis
Source: Eur Respir J 2002; 20: 651-657
Year: 2002
Respiratory syncytial virus infection in childcare and hospitalized children with different respiratory disease severity
Source: Annual Congress 2006 - Virus-induced respiratory tract infection
Year: 2006
Preschool asthma after bronchiolitis in infancy
Source: Eur Respir J 2011; 39: 76-80
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept